11β,21-Dihydroxy-9α-fluoro-16β-methyl-1,4-pregnadiene-3,20-dione

• CAT Number: C000781
• CAS Number: 53798-55-3
• Molecular Formula: C₂₂H₂₉FO₄
• Molecular Weight: 376.46
• Purity: ≥95%
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• Appearance: White to Off-White Solid
• Storage: -20°C, Inert atmosphere
• IUPAC Name: (8S,9R,10S,11S,13S,14S,16S,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
• InChI: InChI=1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,18-,19+,20-,21-,22-/m0/s1
• InChIKey: VWVSBHGCDBMOOT-RSWUNGFYSA-N
• SMILES: CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C

11β,21-Dihydroxy-9α-fluoro-16β-methyl-1,4-pregnadiene-3,20-dione (Cat No.:C000781) is a synthetic corticosteroid compound. Its structure includes a fluorine-substituted pregnane backbone with hydroxyl groups at positions 11 and 21, and a methyl group at position 16. This compound likely holds significance in pharmaceutical research and may have anti-inflammatory or immunosuppressive properties. Researchers may explore its effects on glucocorticoid receptors and its potential therapeutic applications. Investigations into its pharmacological profile, metabolic pathways, and biological interactions could contribute to the development of targeted treatments for various conditions, including inflammatory disorders and autoimmune diseases.

Reference

Ferrante, M.G., et al.: Anal. Profiles Drug Subs., 6, 43 (1977), Li, A., et al.: Chem. Biol. Interact., 142, 7 (2002), Cruz-Monteagudo, M., et al.: Eur. J. Med. Chem., 40, 1030 (2005), Rothfuss, A., et al.: Chem. Res. Toxicol., 19, 1313 (2006),